AKAP13
Basic information
Region (hg38): 15:85380570-85749358
Previous symbols: [ "LBC" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (118 variants)
- not provided (27 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKAP13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | |||||
missense | 111 | 12 | 128 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 111 | 20 | 14 |
Variants in AKAP13
This is a list of pathogenic ClinVar variants found in the AKAP13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-85521464-G-C | not specified | Uncertain significance (Nov 21, 2022) | ||
15-85521518-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
15-85533620-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
15-85533623-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
15-85533860-G-A | not specified | Uncertain significance (Feb 02, 2022) | ||
15-85533870-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
15-85543784-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
15-85543808-T-C | not specified | Uncertain significance (Sep 27, 2021) | ||
15-85543845-G-T | not specified | Uncertain significance (Oct 25, 2023) | ||
15-85543853-C-A | not specified | Uncertain significance (Oct 27, 2023) | ||
15-85543881-C-G | not specified | Uncertain significance (Aug 28, 2023) | ||
15-85543936-C-G | not specified | Uncertain significance (Aug 01, 2022) | ||
15-85575172-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
15-85575184-A-C | not specified | Uncertain significance (Jul 20, 2022) | ||
15-85575219-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
15-85575226-A-C | not specified | Uncertain significance (Nov 10, 2022) | ||
15-85575238-C-G | not specified | Uncertain significance (May 31, 2022) | ||
15-85575283-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
15-85575286-C-G | not specified | Uncertain significance (Nov 02, 2023) | ||
15-85575319-A-C | not specified | Uncertain significance (Oct 14, 2023) | ||
15-85578982-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
15-85579068-G-A | Benign (Apr 30, 2018) | |||
15-85579081-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
15-85579201-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
15-85579216-T-C | not specified | Likely benign (Nov 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AKAP13 | protein_coding | protein_coding | ENST00000361243 | 36 | 368785 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.929 | 0.0709 | 125640 | 0 | 108 | 125748 | 0.000430 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.64 | 1700 | 1.52e+3 | 1.12 | 0.0000823 | 18512 |
Missense in Polyphen | 430 | 448.95 | 0.95779 | 5611 | ||
Synonymous | -3.54 | 677 | 570 | 1.19 | 0.0000318 | 5516 |
Loss of Function | 7.97 | 25 | 119 | 0.211 | 0.00000643 | 1466 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00280 | 0.00280 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.000379 | 0.000378 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000165 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Scaffold protein that plays an important role in assembling signaling complexes downstream of several types of G protein-coupled receptors. Activates RHOA in response to signaling via G protein-coupled receptors via its function as Rho guanine nucleotide exchange factor (PubMed:11546812, PubMed:15229649, PubMed:23090968, PubMed:25186459, PubMed:24993829). May also activate other Rho family members (PubMed:11546812). Part of a kinase signaling complex that links ADRA1A and ADRA1B adrenergic receptor signaling to the activation of downstream p38 MAP kinases, such as MAPK11 and MAPK14 (PubMed:17537920, PubMed:23716597, PubMed:21224381). Part of a signaling complex that links ADRA1B signaling to the activation of RHOA and IKBKB/IKKB, leading to increased NF-kappa-B transcriptional activity (PubMed:23090968). Part of a RHOA-dependent signaling cascade that mediates responses to lysophosphatidic acid (LPA), a signaling molecule that activates G-protein coupled receptors and potentiates transcriptional activation of the glucocorticoid receptor NR3C1 (PubMed:16469733). Part of a signaling cascade that stimulates MEF2C-dependent gene expression in response to lysophosphatidic acid (LPA) (By similarity). Part of a signaling pathway that activates MAPK11 and/or MAPK14 and leads to increased transcription activation of the estrogen receptors ESR1 and ESR2 (PubMed:9627117, PubMed:11579095). Part of a signaling cascade that links cAMP and EGFR signaling to BRAF signaling and to PKA- mediated phosphorylation of KSR1, leading to the activation of downstream MAP kinases, such as MAPK1 or MAPK3 (PubMed:21102438). Functions as scaffold protein that anchors cAMP-dependent protein kinase (PKA) and PRKD1. This promotes activation of PRKD1, leading to increased phosphorylation of HDAC5 and ultimately cardiomyocyte hypertrophy (By similarity). Has no guanine nucleotide exchange activity on CDC42, Ras or Rac (PubMed:11546812). Required for normal embryonic heart development, and in particular for normal sarcomere formation in the developing cardiomyocytes (By similarity). Plays a role in cardiomyocyte growth and cardiac hypertrophy in response to activation of the beta-adrenergic receptor by phenylephrine or isoproterenol (PubMed:17537920, PubMed:23090968). Required for normal adaptive cardiac hypertrophy in response to pressure overload (PubMed:23716597). Plays a role in osteogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q394, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:11579095, ECO:0000269|PubMed:17537920, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:23716597, ECO:0000269|PubMed:24993829, ECO:0000269|PubMed:25186459, ECO:0000269|PubMed:9627117, ECO:0000269|PubMed:9891067}.;
- Pathway
- Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;G Protein Signaling Pathways;Signaling by GPCR;Signal Transduction;rho-selective guanine exchange factor akap13 mediates stress fiber formation;Rho GTPase cycle;Signaling by Rho GTPases;NRAGE signals death through JNK;Death Receptor Signalling;p75 NTR receptor-mediated signalling;G alpha (12/13) signalling events;GPCR downstream signalling;PAR1-mediated thrombin signaling events;Cell death signalling via NRAGE, NRIF and NADE;Regulation of RhoA activity
(Consensus)
Recessive Scores
- pRec
- 0.220
Intolerance Scores
- loftool
- 0.0693
- rvis_EVS
- 1.99
- rvis_percentile_EVS
- 97.64
Haploinsufficiency Scores
- pHI
- 0.222
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.440
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.956
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Akap13
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;G protein-coupled receptor signaling pathway;heart development;positive regulation of Rho protein signal transduction;positive regulation of apoptotic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of MAP kinase activity;regulation of small GTPase mediated signal transduction;nuclear export;cardiac muscle cell differentiation;regulation of sarcomere organization;bone development;cell growth involved in cardiac muscle cell development;adrenergic receptor signaling pathway;adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;regulation of glucocorticoid mediated signaling pathway
- Cellular component
- nucleus;cytosol;actin filament;cell cortex;membrane;cortical actin cytoskeleton;perinuclear region of cytoplasm
- Molecular function
- cAMP-dependent protein kinase activity;MAP-kinase scaffold activity;guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity;protein binding;Rho GTPase binding;protein-containing complex scaffold activity;metal ion binding;protein kinase A binding